The inductive role of dendritic cells (DC) in Th2 differentiation has not been fully defined. We addressed this gap in knowledge by focusing on signaling events mediated by the heterotrimeric GTP binding proteins Gαs, and Gαi, which respectively stimulate and inhibit the activation of adenylyl cyclases and the synthesis of cAMP. We show here that deletion of Gnas, the gene that encodes Gαs in mouse CD11c
The inductive role of dendritic cells (DC) in Th2 differentiation has not been fully defined. We addressed this gap in knowledge by focusing on signaling events mediated by the heterotrimeric GTP binding proteins Gαs, and Gαi, which respectively stimulate and inhibit the activation of adenylyl cyclases and the synthesis of cAMP. We show here that deletion of Gnas, the gene that encodes Gαs in mouse CD11c
+ cells (Gnas ΔCD11c mice), and the accompanying decrease in cAMP provoke Th2 polarization and yields a prominent allergic phenotype, whereas increases in cAMP inhibit these responses. The effects of cAMP on DC can be demonstrated in vitro and in vivo and are mediated via PKA. Certain gene products made by Gnas
ΔCD11c DC affect the Th2 bias. These findings imply that G protein-coupled receptors, the physiological regulators of Gαs and Gαi activation and cAMP formation, act via PKA to regulate Th bias in DC and in turn, Th2-mediated immunopathologies.
cAMP | dendritic cells | Th2 | PKA | asthma T he induction of Th cell response requires antigen-presenting cells (APC), especially dendritic cells (DC), but the mechanisms for this induction have not been fully elucidated (1, 2) . Because DC do not produce IL-4, which is mandatory for GATA3 induction and Th2 cell differentiation (3, 4) , other cell types may be involved in Th2 responses (1, 5, 6) , including basophils (7), epithelial cells (8) , and innate lymphoid cells (ILC), especially ILC group 2 (ILC2) (9) . ILCs are a multifunctional group of cells that are able to secrete immunoregulatory cytokines that affect immune responses. They reside at mucosal surfaces, where they are exposed to microbial or environmental stimulation (10) . Such cells can secrete IL-4 or alarmins, including IL-25, IL-33, and TSLP (epithelial cells), which support Th2 differentiation (11) . Other DC-derived inducers of Th2-differentiation are the Notch ligand Jagged 1 (12) and the interaction between OX40 and OX40L (13) . However, little is known regarding the signaling networks that provoke DC to induce Th2 immunity.
Pharmacological inhibition of cyclic nucleotide phosphodiesterase 4 (PDE4), which is highly expressed in DC, can produce improvement in animal models of inflammation and autoimmunity and can suppress human Th1-polarizing capacity by increasing cAMP concentrations (14, 15) . Based on these findings and our previous work that identified a role for cAMP in DC in Th17 induction (16) , we hypothesized that cAMP regulates DC and affects Th differentiation bias. To test this hypothesis, we studied the regulation of DC activity by heterotrimeric (αβγ) GTP binding proteins that regulate cAMP synthesis through their modulation of the activity of adenylyl cyclases (ACs): Gαs, which stimulates AC activity, and Gαi, which inhibits membrane AC activity.
In the current studies, we engineered mice that have a CD11c-specific deletion of Gnas (CD11c-Cre Gnas fl/fl , i.e., Gnas ΔCD11c ), the gene that encodes Gαs (17) . We found that cAMP accumulation is much less in response to Gαs activation of CD11c + cells from these mice than from littermate (fl/fl) controls. Unexpectedly, the Gnas ΔCD11c mice display a striking phenotype: They develop spontaneous Th2 immunity even though these mice have a C57BL/6 genetic background, which is biased to Th1 immunity (18) . Consequently, these mice develop later airway inflammation that is consistent with allergic asthma (19) . Bone marrow (BM)-derived DC (BMDC) from the Gnas ΔCD11c mice display a pro-Th2 phenotype (i.e., induce a Th2 response when cocultured with CD4 T cells), which can be prevented by treatment with a cAMP analog. Additional studies show that the cAMP effector protein kinase A (PKA) and molecules whose expression is regulated by cAMP play a key role in the induction of the Th2-biased phenotype of DC. The current results thus identify a previously unappreciated role for Gαs-regulated cAMP synthesis and cAMP/PKA in DC in determining Th subset differentiation and resultant responses.
Results
Generation of CD11c-Cre Gnas fl/fl (Gnas
ΔCD11c
) Mice. GPCR-mediated increase in intracellular cAMP requires the activation of AC by Gαs (20) . To obtain mice with DC deficient in this response, we used the Cre-loxP system to generate mice (C57BL/6 background) with a targeted deletion of Gnas in CD11c
+ cells, as we described for CD4 + T cells (21 littermate (fl/fl) control mice (SI Appendix, Fig. S1C ). Thus, the loss of Gnas does not alter the number of peripheral DC or T cells.
Gnas
ΔCD11c Mice Are Atopic and Develop Spontaneous Th2-Mediated
Inflammation. Two-month-old Gnas ΔCD11c mice have increased serum IgE levels but a similar cytokine profile of CD4 + T cells and lung histology compared with cohoused littermate fl/fl mice ( Fig. 1C and SI Appendix, Fig. S1 D and E). We reasoned that if Gnas ΔCD11c mice were immunized with a conventional antigen without an adjuvant and challenged (22) , they would develop Th2-mediated lung inflammation. Indeed, ovalbumin (OVA) immunization (Fig. 1D) provoked strong airway hyperreactivity (AHR), and increased the number of eosinophils in the bronchoalveolar lavage (BAL) fluid, Th2 cytokine response and airway inflammation in the Gnas ΔCD11c , but not littermate fl/fl, mice ( Fig. 1 E-J) . Moreover, 5-to 6-mo-old Gnas ΔCD11c (but not fl/fl) mice develop "spontaneous" Th2 response, i.e., without immunization ( Fig. 2A) , and display features of severe Th2-mediated lung inflammation (i.e., similar to those developed in experimental allergic asthma by OVA/alum immunization and OVA challenge), including AHR (Fig. 2B) , increased number of eosinophils in the BAL fluid (Fig. 2C) , increased serum IgE, IgG1 levels (Fig. 2D) , along with airway inflammation and remodeling (Fig. 2E ). However, 6-mo-old Rag1 −/− or Rag1/ Gnas ΔCD11c double KO (DKO) mice did not demonstrate airway inflammation (Fig. 2F) . Despite their higher IgE serum levels, Gnas ΔCD11c mice housed in the barrier room (where air is filtered and food is sterilized) did not develop Th2 bias or histologic lung abnormalities at 5-6 mo of age (SI Appendix, Fig. S2 ). Interestingly and in contrast to the pathology observed in the airways, we did not identify any overt G-I immunopathology. Collectively, these data indicate that the Gnas ΔCD11c mice are atopic; they are poised to mount "spontaneous" Th2 bias Fig. S3A ). We then isolated CD11c
+ doublepositive cells by FACS (SI Appendix, Fig. S4A ) (23, 24) and cocultured these cells with FACS-sorted naïve OT2 splenic CD4 + T cells for 3 d. BMDC derived from Gnas ΔCD11c mice (but not from fl/fl controls) induced high (seven-to ninefold increased) levels of IL-4 in the cocultured OT2 CD4 + T cells ( Fig. 3 A and B) . IL-4 eGFP reporter/OT2 (4Get/OT2) CD4
+ T cells cocultured with Gnas
ΔCD11c BMDC had a 17.9-fold increase in eGFP expression (Fig. 3C) . Cocultured OT2 CD4
+ T cells displayed very high expression levels of Th2 cell marker T1/ST2 (25) (45-fold increase, Fig. 3D ). Analysis of the Th lineage commitment factors of these cocultured OT2 CD4 + T cells revealed higher GATA3 levels (2.6-fold increase, Fig. 3E ), indicating that BMDC from Gnas ΔCD11c mice have a pro-Th2 phenotype, i.e., they induce Th2 differentiation. However, these BMDC did not display altered expression of Th2-promoting cognate molecules, such as Jagged 1 (12), OX40L (13) or FceR1 (26) (Fig. 3F) . CD11c
+ single-positive cells from Gnas ΔCD11c mice provoked a similar response (SI Appendix, Fig. S4 A-C) . Because GM-CSFderived BMDC enhance development of inflammatory DC (27), we also stimulated BM cultures with Flt3 ligand, which promotes development of both plasmacytoid and conventional DC (23) . Incubation with Flt3 ligand promoted an increase in CD11c + expression in BM cultures similar to that produced by GM-CSF (SI Appendix, Fig. S3B ). Flt3-derived CD11c + BM cells from Gnas ΔCD11c (but not fl/fl) mice provoked a Th2 bias in the CD4 + T-cell differentiation assay (SI Appendix, Fig. S4D ). CD11c
+ BM cells are a small fraction of the CD11c + BM cells (SI Appendix, Fig. S4A ), and because double-positive and the singlepositive BM cells displayed a similar pro-Th2 phenotype, we undertook further in vitro analyses using CD11c + BM cells (i.e., single-positive BMDC).
We also analyzed the function of FACS-isolated lung DC subsets on the OT2 Th2 cell differentiation. Resident lung DC from Gnas ΔCD11c mice (Fig. 3G ), but not alveolar macrophages (Fig. 3H) , induced a Th2 bias ex vivo. Another lung DC subset, lung inflammatory DC, isolated from OVA/alum-immunized and OVA-challenged (22) , Gnas ΔCD11c mice also displayed an increase in their pro-Th2 phenotype (Fig. 3I) . Collectively, these data indicate that interaction of CD11c + DC and CD4 + T cells is sufficient to provoke Th2 differentiation in this coculture system in vitro and ex vivo.
To assess Th2 differentiation in vivo, we transferred naïve 4Get CD4
+ T cells (28, 29) into Rag1 −/− or Rag1/Gnas ΔCD11c DKO mice and 3 wk later analyzed eGFP fluorescence in splenic T cells. We found that >20% of the CD4 + T cells isolated from the DKO mice were eGFP-positive compared with those from the Rag1 −/− mice (Fig. 3J) . Together with the findings from the ex vivo studies, these results show the crucial role of CD11c +
DC-derived from Gnas
ΔCD11c mice in the induction of Th2 bias.
PKA and Gαi Signaling Regulate the Induction of the Pro-Th2
Phenotype of BMDC. The results shown thus far provide evidence for the pro-Th2 phenotype of BMDC and lung DC from Gnas
ΔCD11c
. To explore the possible inhibitory role of cAMP on Th2-mediated immunity, we incubated BMDC with the cellpermeable cAMP analog, 8-CPT-cAMP (CPT). Incubation with CPT abolished the subsequent production of IL-4 by cocultured OT2 CD4 + T cells (Fig. 4A) . We analyzed the two main cAMP signaling effectors, PKA and Exchange protein activated by cAMP (EPAC), for their role in the pro-Th2 phenotype of BMDC of Gnas ΔCD11c mice. Treatment with N6, a PKA-selective cAMP agonist, but not with 8ME, an EPAC agonist, abolished the pro-Th2 phenotype of Gnas ΔCD11c BMDC (Fig. 4B) . Moreover, treatment of wild-type (WT)-BMDC with a PKA inhibitor (H-89), but not an EPAC inhibitor (CE3F4), promoted their pro-Th2 phenotype (Fig. 4C) . These data implicate cAMP-PKA signaling in the inhibition of induction of the pro-Th2 phenotype of DC.
The deletion of Gnas in CD11c + cells alters the balance between Gαs and Gαi in terms of cAMP synthesis and action in favor of Gαi signaling. To assess the role of Gαi, we incubated WT-BMDC with the Gαi activator mastoparan, a peptide toxin from wasp venom (30) . Incubation with mastoparan 7 (MP7) (31) induced a pro-Th2 phenotype in WT-BMDC (Fig. 4D ). Moreover, incubation of H-89-treated or MP7-treated WT-BMDC with pertussis toxin (PTX), which blocks Gαi activation, inhibited this pro-Th2 phenotype (Fig. 4 C and D) . suppressed their pro-Th2 phenotype (Fig. 4E) . Thus, cAMP-PKA signaling inhibits the pro-Th2 phenotype of both WT and Gnas ΔCD11c BMDC and activation of Gαi contributes to the proTh2 phenotype of the latter cells. This result implies that the proTh2 phenotype in the Gnas-depleted CD11c + cells reflects an altered Gαs/Gαi balance in the activation of AC, and derives from a decrease in cAMP concentration and reduced PKA activation in DC.
Identification of Th2 Biasing Molecules in Gnas
ΔCD11c BMDC. Using DNA microarray analysis, we found 1,910 genes differentially expressed in BMDC of the Gnas ΔCD11c mice compared with fl/fl mice (Dataset S1 and Fig. 5A ). An enrichment analysis of the 670 genes that had >twofold difference in expression revealed that there was enrichment in immune response and cell cycle genes, suggesting that the decrease in Gαs expression and cAMP concentration may alter the proliferation of BMDC in Gnas ΔCD11c mice (SI Appendix, Tables S1 and S2). Network analysis of transcription factors driving the expression profile identified cAMP response element-binding protein-1 (CREB1) as the most important transcriptional regulator (SI Appendix, Table S3 ) with 29% of the differentially regulated genes being CREB targets (SI Appendix, Fig. S5 ).
The transcriptomic analysis revealed gene products that may induce Th2 differentiation. Hematopoietic prostaglandin D synthase (Hpgds) was increased in Gnas ΔCD11c BMDC (Dataset S1). Its product, PGD 2 , binds to CRTH2 on CD4 T cells (32) and induces Th2 differentiation. We confirmed the increased transcript levels of Hpgds in Gnas ΔCD11c BMDC by qPCR and its inhibition by CPT (i.e., increase in cellular cAMP levels) (Fig. 5B) . Moreover, DC transfected with Hpgds siRNA (SI Appendix, Fig.  S6A ) inhibited expression of the pro-Th2 phenotype (Fig. 5C ).
The transcript of CCL2 (MCP-1) (Dataset S1 and Fig. 5D ), a chemokine that activates the Gαi-linked GPCR, CCR2, is highly increased in Gnas ΔCD11c BMDC. CCL2 can regulate Th2 commitment and IL-4 expression (33). Treatment with CPT inhibited CCL2 expression (Fig. 5D ) and addition of a CCL2 neutralizing Ab inhibited the pro-Th2 phenotype of Gnas ΔCD11c BMDC (Fig.  5E) . Furthermore, CCR2 blockade of OT2 T cells, but not of BMDC, reduced IL-4 production in coculture with Gnas
ΔCD11c
BMDCs; thus, CCL2 secreted from DCs also induces the pro-Th2 phenotype (Fig. 5F ). Hgpds and CCL2 are each regulated by cAMP but their regulation is independent of one another (SI Appendix, Fig. S6 ). Taken together, these results imply that multiple cAMP-regulated genes in DC may contribute to the Th2 bias observed in Gnas ΔCD11c mice and help determine the propensity for Th2 in WT mice.
Adoptive Transfer of BMDC from Gnas
ΔCD11c Mice Induces a Th2 Bias
in WT Recipients and Increasing cAMP Concentration in Those Cells
Blocks It. The cAMP agonist CPT inhibits the pro-Th2 phenotype of Gnas ΔCD11c BMDC (Fig. 4A) . We used adoptive transfer (34) to assess for the in vivo relevance of this finding (Fig. 6A) . Intranasal transfer of OVA-loaded BMDC from Gnas ΔCD11c mice induced OVA-specific IL-4 by splenic CD4 + T cells (Fig. 6B ), higher levels of IgE (Fig. 6C) , and airway inflammation (Fig. 6D ) in WT and Gnas ΔCD11c recipients. However, treatment with CPT of Gnas ΔCD11c BMDC before transfer to recipient mice inhibited development of Th2 bias and airway inflammation in the recipients (Fig. 6 B-D) . Thus, increased cAMP concentration and signaling inhibits the pro-Th2 phenotype of BMDC from Gnas ΔCD11c mice both in vitro and in vivo.
Discussion
Advances in the studies of innate and adaptive immunity have revealed the molecular basis of Th1, Th17, and Treg induction by DC (35) . Such studies also showed the important role of activation of pattern recognition receptors (PRR) by microbial products in the differentiation of the Th1/Th17 subsets (36, 37) . In contrast, the mechanisms by which DC induce a Th2 response remain obscure, and thus, the involvement of other cell types has been proposed (7, 8) , especially ILC2 (9) . The data presented here indicate that a Gαs/Gαi signaling imbalance that favors a low cAMP concentration in BMDC and lung CD11c + DC provokes a Th2 response (Fig. 3) , which is reversed by increasing cAMP content and PKA activation in DC (Fig. 4) . These data, combined with our previous observations that show induction of Th17 response (16) by high levels of cAMP in DC mostly via Gαs activation, indicate that in addition to PRR, signaling via regulators of cAMP levels, Gαs, and Gαi in CD11c
+ DC (and not in CD11c − ILC2 cells) (38) contributes to Th subset differentiation. Furthermore, the current findings help explain certain previous data, for example evidence that CGRP, a neuronally derived peptide that binds to a Gs-coupled receptor, can be an antiinflammatory mediator in the setting of allergic airway inflammation (39) .
Although Gnas ΔCD11c mice are atopic from an early age ( Fig.  1) , conditions that influence the microbiota have been proposed to affect a Th2 bias and induction of Th2-mediated airway inflammation (40) . Indeed, high serum IgE levels were found in germ-free mice (41) . We question whether the microbiome of our Gnas ΔCD11c mice has a substantial impact on their Th2 bias for the following reasons: (i) Our mice were raised under specific pathogen-free (SPF) and not under germ-free conditions. (ii) BM cells from Gnas ΔCD11c , but not fl/fl, mice that were cultured and differentiated for 7 d in vitro under sterile conditions induce Th2 bias of OT2 CD4
+ T cells (Fig. 3 A and B) , which was abolished by cell permeable cAMP (Fig. 4 A and B) . (iii) Blocking PKA signaling (H89) or activating Gai (mastoparan) in WT BMDC provokes a Th2 bias, results that are consistent with the signaling pathway that induces the Th2 bias by Gnas ΔCD11c BMDC (Fig. 4 C and D) . (iv) Our breeding strategy provides both fl/fl and Gnas ΔCD11c littermates and their cohousing for 6 mo did not induce Th2 bias or any other change in the CD4 + T-cell response in the fl/fl mice nor did it affect development of Th2 bias in the Gnas ΔCD11c mice (SI Appendix, Fig. S2 ). (v) Injection of sterile antigen (OVA) was sufficient to provoke an OVA-specific Th2 response in young Gnas
ΔCD11c
, but not fl/fl, mice ( Fig. 1 E-H) . (vi) The Gnas ΔCD11c mice are atopic at an early age and develop Th2 bias in a time-dependent manner (by age 5-6 mo) under SPF conditions (Fig. 2) . Collectively, although our results do not rule out alterations in the microbioata composition in the Gnas ΔCD11c mice, these findings argue for gene-environment interactions other than with the microbiome as the main drivers of the Th2 bias and the development of Th2-mediated murine asthma (42) .
We found that the wasp venom-derived Gαi agonist mastoparan induces the pro-Th2 DC phenotype in WT-BMDC and that inhibition of Gαi signaling (i.e., treatment with PTX) suppresses this phenotype in WT-BMDC and the pro-Th2 phenotype of Gnas ΔCD11c mice (Fig. 4) . Mastoparan is derived from yellow jackets (Vespula vulgaris) and shares certain activities (43) with melittin, the principal active component of bee venom; activities of mellitin include Gαi activation and Gαs inhibition (44) . It is intriguing to speculate that a decrease in cAMP concentrations in DC at the sting areas of affected individuals may be a mechanism by which Hymenoptera venoms induce Th2 bias and allergy in humans.
Our results indicate that the activation of PKA inhibits the pro-Th2 phenotype of Gnas ΔCD11c BMDC and suggest that the inhibition of PKA induces a pro-Th2 phenotype in WT-BMDC (Fig. 4) . Transcriptomic analysis of Gnas ΔCD11c BMDC identified 2 cAMP-regulated gene products (Hpgds and CCL2) that affect the pro-Th2 phenotype of BMDC ex vivo (Dataset S1 and Fig. 5 ) and have been reported to contribute to Th2 immunity and asthma in vivo (45, 46) . Those genes and perhaps others (Dataset S1) are predicted to mediate the induction of Th2 by Gnas ΔCD11c BMDC. Overall, our data indicate that a balance between Gαs and Gαi signaling appears to determine the pro-Th2 phenotype in both WT and Gnas ΔCD11c BMDC. Consistent with this idea, transcriptomic analysis points to a role for CREB in mediating cAMP effects that determine the pro-Th2 phenotype of DC (SI Appendix, Fig. S5) .
Numerous animal models have been used to explore the pathogenesis of allergic disorders (47, 48) . However, the failure to translate drug candidates identified in such models to humans with those diseases raises questions regarding the utility of those models and emphasizes a need for new models that more accurately reflect human immunology and genetics (49) . The increasing prevalence of allergic diseases during recent decades imposes significant public health challenges and has substantial health care-related costs (50) (51) (52) . The pathophysiology of Gnas ΔCD11c mice mimics that observed in allergic/asthmatic patients: Gnas ΔCD11c mice are atopic, develop spontaneous Th2 response and a progressive chronic allergic phenotype that is akin to what occurs in patients with allergic asthma. Thus, Gnas ΔCD11c mice may be a unique platform to identify novel molecular effectors of Th2 differentiation, their role in the induction of the allergic phenotype and the related airway inflammation.
Gnas ΔCD11c mice may facilitate the discovery and testing of new therapeutics to prevent and treat allergy and asthma in humans. Based on the results shown here, we propose that targeting of DC-expressed GPCRs, the physiological activators of Gαs and Gαi (and thus the regulators of cAMP formation) may provide such a therapeutic approach. Alternative means of influencing cAMP/PKA signaling can be envisaged but the wide utility and safety of drugs directed at GPCRs, including in the treatment of clinical features of allergic disorders, favor such receptors as attractive targets for developing DC-directed therapy that will influence Th2 immunity and its consequent immunopathologies.
Materials and Methods
C57BL/6 (B6) mice were purchased from Harlan Laboratories. CD11c-Cre transgenic mice and OT2 (B6) were purchased from The Jackson Laboratory.
To generate Gαs-deficient dendritic cells, lox-flanked Gnas (23) (a kind gift from Lee Weinstein, NIH) were crossed to CD11c-Cre mice. The CD11c + cells in the Cre + Gnas ΔCD11c mice were determined to be Gnas
ΔCD11c
. The fl/fl littermates (Cre − Gnas fl/fl ) or B6 were used as control. IL4-eGFP reporter (4Get) mice originally made by Dr. Richard Locksley (University of California, San Francisco) were a gift from Mitchell Kronenberg (La Jolla Institute for Allergy and Immunology, La Jolla, CA). 4Get mice were bred to OT2 mice to yield 4Get/OT2 mice. As outlined in Results, these animals were used in selected experiments. All mice were kept in a SPF facility. For details of experimental conditions and analysis, see SI Appendix, SI Materials and Methods.
